Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Growth Hormone-Releasing Hormone | 17 | 2024 | 126 | 5.010 |
Why?
|
Human Growth Hormone | 14 | 2020 | 640 | 2.120 |
Why?
|
Intra-Abdominal Fat | 11 | 2023 | 624 | 1.890 |
Why?
|
Williams Syndrome | 4 | 2021 | 195 | 1.690 |
Why?
|
Fatty Liver | 6 | 2020 | 810 | 1.670 |
Why?
|
HIV Infections | 46 | 2024 | 17536 | 1.490 |
Why?
|
Insulin-Like Growth Factor I | 14 | 2021 | 1935 | 1.480 |
Why?
|
Body Composition | 18 | 2021 | 2441 | 1.410 |
Why?
|
Dwarfism, Pituitary | 2 | 2020 | 39 | 1.080 |
Why?
|
Adiposity | 12 | 2024 | 1892 | 1.040 |
Why?
|
HIV-Associated Lipodystrophy Syndrome | 3 | 2017 | 137 | 0.780 |
Why?
|
Genitalia | 1 | 2022 | 114 | 0.780 |
Why?
|
Contraceptives, Oral, Combined | 1 | 2021 | 116 | 0.710 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 1 | 2021 | 208 | 0.670 |
Why?
|
Menstruation | 1 | 2021 | 310 | 0.660 |
Why?
|
Obesity | 23 | 2024 | 13090 | 0.650 |
Why?
|
Anti-Obesity Agents | 2 | 2020 | 241 | 0.640 |
Why?
|
Endocrinology | 2 | 2022 | 441 | 0.640 |
Why?
|
Blood Glucose | 13 | 2021 | 6422 | 0.620 |
Why?
|
Bone Density | 3 | 2021 | 3491 | 0.590 |
Why?
|
Growth Hormone | 4 | 2020 | 572 | 0.520 |
Why?
|
Insulin Resistance | 7 | 2018 | 3989 | 0.510 |
Why?
|
Subcutaneous Fat | 4 | 2021 | 401 | 0.480 |
Why?
|
Liver | 10 | 2023 | 7571 | 0.470 |
Why?
|
Carotid Arteries | 4 | 2013 | 932 | 0.460 |
Why?
|
Adrenal Insufficiency | 3 | 2023 | 194 | 0.460 |
Why?
|
Lipid Metabolism | 4 | 2018 | 1895 | 0.460 |
Why?
|
Anti-HIV Agents | 6 | 2020 | 4562 | 0.440 |
Why?
|
Abdominal Fat | 2 | 2014 | 217 | 0.430 |
Why?
|
Weight Loss | 5 | 2020 | 2712 | 0.420 |
Why?
|
Quinolines | 1 | 2018 | 769 | 0.420 |
Why?
|
Pituitary Gland | 2 | 2018 | 635 | 0.420 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 2 | 2012 | 416 | 0.410 |
Why?
|
Double-Blind Method | 9 | 2024 | 12430 | 0.390 |
Why?
|
Fibroblast Growth Factors | 1 | 2017 | 871 | 0.380 |
Why?
|
Receptors, Tumor Necrosis Factor | 2 | 2010 | 588 | 0.370 |
Why?
|
HIV | 6 | 2023 | 1588 | 0.350 |
Why?
|
Metabolic Diseases | 2 | 2014 | 686 | 0.340 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2011 | 279 | 0.340 |
Why?
|
HIV Protease Inhibitors | 4 | 2009 | 430 | 0.330 |
Why?
|
Adrenoleukodystrophy | 2 | 2023 | 144 | 0.320 |
Why?
|
Adipokines | 1 | 2010 | 308 | 0.310 |
Why?
|
HIV Wasting Syndrome | 8 | 2001 | 99 | 0.300 |
Why?
|
Tunica Media | 3 | 2013 | 107 | 0.280 |
Why?
|
Overweight | 1 | 2018 | 2446 | 0.280 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2020 | 3250 | 0.280 |
Why?
|
Placebos | 6 | 2024 | 1659 | 0.280 |
Why?
|
Humans | 99 | 2024 | 766766 | 0.270 |
Why?
|
Glucose Clamp Technique | 3 | 2018 | 262 | 0.270 |
Why?
|
Adult | 57 | 2024 | 223307 | 0.270 |
Why?
|
Cardiovascular Diseases | 12 | 2023 | 15657 | 0.270 |
Why?
|
Insulin | 6 | 2018 | 6608 | 0.260 |
Why?
|
Parathyroid Hormone | 1 | 2012 | 1791 | 0.260 |
Why?
|
Phosphocreatine | 3 | 2010 | 259 | 0.250 |
Why?
|
Adolescent | 27 | 2022 | 88904 | 0.250 |
Why?
|
C-Reactive Protein | 3 | 2013 | 3853 | 0.250 |
Why?
|
Female | 63 | 2024 | 396520 | 0.250 |
Why?
|
Male | 68 | 2024 | 364142 | 0.250 |
Why?
|
Body Mass Index | 13 | 2023 | 13050 | 0.250 |
Why?
|
Tunica Intima | 3 | 2013 | 455 | 0.250 |
Why?
|
Blood Proteins | 2 | 2021 | 1194 | 0.250 |
Why?
|
Young Adult | 22 | 2022 | 59939 | 0.240 |
Why?
|
Middle Aged | 48 | 2024 | 223257 | 0.240 |
Why?
|
Inflammation | 6 | 2024 | 10860 | 0.240 |
Why?
|
Testosterone | 9 | 2019 | 2495 | 0.240 |
Why?
|
Body Height | 3 | 2010 | 1562 | 0.240 |
Why?
|
Minority Groups | 2 | 2021 | 1208 | 0.230 |
Why?
|
Monocytes | 4 | 2022 | 2600 | 0.220 |
Why?
|
Vitamin D | 2 | 2019 | 3270 | 0.220 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2008 | 391 | 0.220 |
Why?
|
Muscle, Skeletal | 7 | 2015 | 4970 | 0.210 |
Why?
|
Renin-Angiotensin System | 3 | 2018 | 737 | 0.210 |
Why?
|
Lipodystrophy | 3 | 2016 | 145 | 0.210 |
Why?
|
Immunoglobulin G | 2 | 2010 | 4559 | 0.190 |
Why?
|
Alanine Transaminase | 3 | 2021 | 608 | 0.190 |
Why?
|
Case-Control Studies | 11 | 2020 | 22248 | 0.180 |
Why?
|
Absorptiometry, Photon | 5 | 2024 | 1707 | 0.180 |
Why?
|
Glucose Tolerance Test | 3 | 2012 | 1180 | 0.170 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 2 | 2018 | 281 | 0.170 |
Why?
|
Body Weight | 6 | 2023 | 4626 | 0.160 |
Why?
|
Heart | 4 | 2022 | 4425 | 0.160 |
Why?
|
Growth Substances | 1 | 2021 | 759 | 0.160 |
Why?
|
Proteomics | 3 | 2023 | 3914 | 0.160 |
Why?
|
Antiretroviral Therapy, Highly Active | 3 | 2020 | 1900 | 0.150 |
Why?
|
Growth Disorders | 1 | 2022 | 634 | 0.150 |
Why?
|
Aspartate Aminotransferases | 2 | 2017 | 416 | 0.150 |
Why?
|
Eating | 2 | 2023 | 1539 | 0.140 |
Why?
|
HIV-1 | 4 | 2019 | 6948 | 0.140 |
Why?
|
Glucose | 1 | 2009 | 4340 | 0.140 |
Why?
|
gamma-Glutamyltransferase | 1 | 2017 | 142 | 0.140 |
Why?
|
Myocardium | 2 | 2020 | 4765 | 0.140 |
Why?
|
Fibrosis | 2 | 2022 | 2077 | 0.130 |
Why?
|
Magnetic Resonance Spectroscopy | 5 | 2019 | 3681 | 0.130 |
Why?
|
Child | 11 | 2023 | 80668 | 0.130 |
Why?
|
T-Lymphocyte Subsets | 1 | 2024 | 1814 | 0.130 |
Why?
|
Hormones | 1 | 2019 | 866 | 0.130 |
Why?
|
Cranial Irradiation | 1 | 2018 | 392 | 0.130 |
Why?
|
Emergency Treatment | 1 | 2019 | 495 | 0.120 |
Why?
|
Macrophage Activation | 1 | 2018 | 553 | 0.120 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 2021 | 1142 | 0.120 |
Why?
|
Treatment Outcome | 9 | 2024 | 65273 | 0.120 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2015 | 393 | 0.110 |
Why?
|
Triglycerides | 2 | 2019 | 2441 | 0.110 |
Why?
|
Adipose Tissue | 6 | 2024 | 3314 | 0.110 |
Why?
|
Hypothalamus | 1 | 2018 | 1003 | 0.110 |
Why?
|
Sex Hormone-Binding Globulin | 3 | 2019 | 557 | 0.100 |
Why?
|
Ideal Body Weight | 1 | 2012 | 27 | 0.100 |
Why?
|
California | 1 | 2017 | 1435 | 0.100 |
Why?
|
Glucose Transporter Type 2 | 1 | 2012 | 61 | 0.100 |
Why?
|
Hypercalciuria | 1 | 2012 | 31 | 0.100 |
Why?
|
Hypophosphatemia, Familial | 1 | 2012 | 32 | 0.100 |
Why?
|
Aged | 14 | 2021 | 171343 | 0.100 |
Why?
|
Lipids | 6 | 2018 | 3319 | 0.100 |
Why?
|
Fanconi Syndrome | 1 | 2012 | 35 | 0.100 |
Why?
|
Pregnancy Complications, Infectious | 2 | 2021 | 2184 | 0.100 |
Why?
|
Macrophages | 2 | 2024 | 5783 | 0.100 |
Why?
|
Placenta | 1 | 2021 | 1725 | 0.100 |
Why?
|
Rickets | 1 | 2012 | 66 | 0.100 |
Why?
|
Vascular Diseases | 1 | 2020 | 1161 | 0.100 |
Why?
|
Fibronectins | 1 | 2015 | 722 | 0.100 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2022 | 2143 | 0.100 |
Why?
|
Receptors, Cell Surface | 2 | 2018 | 2815 | 0.090 |
Why?
|
Hypogonadism | 5 | 2019 | 802 | 0.090 |
Why?
|
Age Determination by Skeleton | 1 | 2012 | 124 | 0.090 |
Why?
|
Hypolipidemic Agents | 1 | 2015 | 609 | 0.090 |
Why?
|
Hepatitis C, Chronic | 1 | 2019 | 1033 | 0.090 |
Why?
|
Societies | 2 | 2021 | 106 | 0.090 |
Why?
|
Plaque, Atherosclerotic | 1 | 2022 | 1535 | 0.090 |
Why?
|
Sodium | 1 | 2016 | 1594 | 0.090 |
Why?
|
Heart Failure | 4 | 2022 | 11882 | 0.090 |
Why?
|
Radiation Injuries | 1 | 2018 | 1194 | 0.090 |
Why?
|
Feeding Behavior | 1 | 2023 | 3208 | 0.090 |
Why?
|
Tomography, X-Ray Computed | 5 | 2019 | 20708 | 0.090 |
Why?
|
Cardiomyopathies | 2 | 2020 | 2059 | 0.090 |
Why?
|
Sulfotransferases | 1 | 2011 | 150 | 0.090 |
Why?
|
Antigens, CD | 2 | 2018 | 4032 | 0.090 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 1 | 2011 | 178 | 0.090 |
Why?
|
Longitudinal Studies | 6 | 2023 | 14762 | 0.090 |
Why?
|
Proteome | 1 | 2020 | 1894 | 0.090 |
Why?
|
Gene Expression | 2 | 2020 | 7585 | 0.090 |
Why?
|
Infant, Newborn | 4 | 2023 | 26389 | 0.090 |
Why?
|
Pyrazines | 1 | 2015 | 1204 | 0.080 |
Why?
|
Anti-Retroviral Agents | 3 | 2020 | 1787 | 0.080 |
Why?
|
Glucocorticoids | 1 | 2019 | 2158 | 0.080 |
Why?
|
Health Status Indicators | 1 | 2014 | 968 | 0.080 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2011 | 4349 | 0.080 |
Why?
|
Vitamin D Deficiency | 1 | 2019 | 1349 | 0.080 |
Why?
|
CD4 Lymphocyte Count | 6 | 2020 | 2586 | 0.080 |
Why?
|
Lipoproteins, LDL | 1 | 2012 | 642 | 0.080 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 2 | 2021 | 3246 | 0.080 |
Why?
|
Adiponectin | 2 | 2011 | 1121 | 0.080 |
Why?
|
Exercise | 5 | 2010 | 5945 | 0.080 |
Why?
|
E-Selectin | 1 | 2010 | 575 | 0.070 |
Why?
|
Immunity | 2 | 2024 | 1002 | 0.070 |
Why?
|
Ritonavir | 1 | 2009 | 331 | 0.070 |
Why?
|
Adrenal Glands | 2 | 2008 | 556 | 0.070 |
Why?
|
Body Fat Distribution | 1 | 2009 | 246 | 0.070 |
Why?
|
Lipoproteins, HDL | 1 | 2012 | 677 | 0.070 |
Why?
|
Pilot Projects | 1 | 2020 | 8728 | 0.070 |
Why?
|
Liver Cirrhosis | 3 | 2023 | 1960 | 0.070 |
Why?
|
Pyrimidinones | 1 | 2009 | 385 | 0.070 |
Why?
|
Atherosclerosis | 1 | 2022 | 3420 | 0.070 |
Why?
|
Neonatal Screening | 2 | 2023 | 619 | 0.070 |
Why?
|
Puberty | 1 | 2009 | 495 | 0.070 |
Why?
|
Societies, Medical | 1 | 2018 | 3957 | 0.070 |
Why?
|
Neck | 1 | 2011 | 735 | 0.070 |
Why?
|
Prevalence | 5 | 2020 | 15835 | 0.060 |
Why?
|
Obesity, Morbid | 2 | 2014 | 1292 | 0.060 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2014 | 2028 | 0.060 |
Why?
|
Ovary | 2 | 2008 | 963 | 0.060 |
Why?
|
Luteinizing Hormone | 1 | 2008 | 828 | 0.060 |
Why?
|
Sex Characteristics | 3 | 2010 | 2645 | 0.060 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2023 | 12245 | 0.060 |
Why?
|
Metabolome | 1 | 2012 | 1009 | 0.060 |
Why?
|
Gastric Bypass | 1 | 2013 | 820 | 0.060 |
Why?
|
Carotid Artery Diseases | 1 | 2010 | 872 | 0.060 |
Why?
|
Prediabetic State | 1 | 2010 | 547 | 0.060 |
Why?
|
Analysis of Variance | 2 | 2011 | 6214 | 0.060 |
Why?
|
Oxidative Phosphorylation | 2 | 2020 | 502 | 0.060 |
Why?
|
Blood Pressure | 5 | 2020 | 8533 | 0.060 |
Why?
|
Diet, Sodium-Restricted | 2 | 2016 | 291 | 0.060 |
Why?
|
Bariatric Surgery | 1 | 2014 | 996 | 0.060 |
Why?
|
Oligopeptides | 1 | 2009 | 1195 | 0.060 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7431 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15908 | 0.050 |
Why?
|
Aging | 2 | 2020 | 8731 | 0.050 |
Why?
|
Steroids | 1 | 2008 | 936 | 0.050 |
Why?
|
Hydrocortisone | 3 | 2019 | 1838 | 0.050 |
Why?
|
Prognosis | 2 | 2020 | 29948 | 0.050 |
Why?
|
Mitochondria | 1 | 2015 | 3677 | 0.050 |
Why?
|
United States | 6 | 2021 | 72951 | 0.050 |
Why?
|
HIV Integrase Inhibitors | 1 | 2024 | 165 | 0.050 |
Why?
|
Age Factors | 2 | 2017 | 18397 | 0.050 |
Why?
|
Aldosterone | 2 | 2018 | 881 | 0.050 |
Why?
|
Risk Factors | 8 | 2023 | 74881 | 0.050 |
Why?
|
Viral Load | 3 | 2020 | 3385 | 0.050 |
Why?
|
Hawaii | 1 | 2021 | 101 | 0.050 |
Why?
|
Appetite | 1 | 2023 | 247 | 0.050 |
Why?
|
Potassium Radioisotopes | 1 | 2000 | 12 | 0.050 |
Why?
|
Weight Gain | 2 | 2023 | 2356 | 0.050 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2014 | 1897 | 0.040 |
Why?
|
Osteopontin | 1 | 2022 | 305 | 0.040 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2023 | 461 | 0.040 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2010 | 2270 | 0.040 |
Why?
|
Child, Preschool | 3 | 2018 | 42577 | 0.040 |
Why?
|
Mitochondria, Muscle | 2 | 2010 | 171 | 0.040 |
Why?
|
Gene Expression Regulation | 1 | 2017 | 11920 | 0.040 |
Why?
|
Receptors, Chemokine | 1 | 2022 | 652 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2021 | 39309 | 0.040 |
Why?
|
Interleukin-18 | 1 | 2021 | 251 | 0.040 |
Why?
|
Arteries | 1 | 2024 | 1123 | 0.040 |
Why?
|
Coronary Artery Disease | 1 | 2019 | 6558 | 0.040 |
Why?
|
Cohort Studies | 4 | 2021 | 41710 | 0.040 |
Why?
|
Arginine | 3 | 2010 | 932 | 0.040 |
Why?
|
Diagnostic Techniques, Endocrine | 1 | 2018 | 43 | 0.040 |
Why?
|
Genetic Testing | 1 | 2012 | 3591 | 0.040 |
Why?
|
Hepatitis | 1 | 2020 | 226 | 0.040 |
Why?
|
Early Diagnosis | 1 | 2023 | 1186 | 0.040 |
Why?
|
Ventricular Function, Left | 2 | 2022 | 3935 | 0.040 |
Why?
|
Positron-Emission Tomography | 1 | 2014 | 6550 | 0.040 |
Why?
|
Reference Values | 3 | 2018 | 4913 | 0.040 |
Why?
|
Cross-Sectional Studies | 6 | 2022 | 26310 | 0.040 |
Why?
|
Pyridines | 1 | 2009 | 2888 | 0.040 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2021 | 637 | 0.040 |
Why?
|
Brain Neoplasms | 1 | 2018 | 9101 | 0.030 |
Why?
|
Hyperinsulinism | 1 | 2000 | 402 | 0.030 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2018 | 618 | 0.030 |
Why?
|
Endocrine System Diseases | 1 | 2018 | 247 | 0.030 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2018 | 638 | 0.030 |
Why?
|
Pregnancy | 3 | 2023 | 30237 | 0.030 |
Why?
|
Birth Weight | 1 | 2023 | 2123 | 0.030 |
Why?
|
Waist Circumference | 1 | 2019 | 934 | 0.030 |
Why?
|
North America | 1 | 2018 | 1287 | 0.030 |
Why?
|
Regression Analysis | 3 | 2012 | 6329 | 0.030 |
Why?
|
Retrospective Studies | 5 | 2023 | 81635 | 0.030 |
Why?
|
Androgens | 1 | 2001 | 1280 | 0.030 |
Why?
|
Muscles | 1 | 1999 | 1576 | 0.030 |
Why?
|
Chemokine CCL2 | 1 | 2016 | 604 | 0.030 |
Why?
|
Up-Regulation | 1 | 2023 | 4142 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 4 | 2024 | 36567 | 0.030 |
Why?
|
Diabetes Mellitus | 1 | 2012 | 5887 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2012 | 20144 | 0.030 |
Why?
|
Hypopituitarism | 1 | 2015 | 253 | 0.030 |
Why?
|
Exercise Therapy | 1 | 2000 | 938 | 0.030 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2017 | 878 | 0.030 |
Why?
|
Transaminases | 1 | 2014 | 198 | 0.030 |
Why?
|
Comorbidity | 1 | 2008 | 10580 | 0.030 |
Why?
|
Sodium-Phosphate Cotransporter Proteins, Type IIc | 1 | 2012 | 14 | 0.030 |
Why?
|
Aorta | 1 | 2020 | 2043 | 0.030 |
Why?
|
Area Under Curve | 2 | 2010 | 1638 | 0.030 |
Why?
|
Sodium-Phosphate Cotransporter Proteins, Type IIa | 1 | 2012 | 44 | 0.030 |
Why?
|
Liver Function Tests | 1 | 2014 | 527 | 0.030 |
Why?
|
Angiotensin II | 1 | 2015 | 844 | 0.020 |
Why?
|
Glucose Transporter Type 1 | 1 | 2012 | 186 | 0.020 |
Why?
|
Obesity, Abdominal | 1 | 2015 | 371 | 0.020 |
Why?
|
Energy Metabolism | 2 | 2015 | 2903 | 0.020 |
Why?
|
Models, Biological | 1 | 2008 | 9461 | 0.020 |
Why?
|
Signal Transduction | 1 | 2014 | 23619 | 0.020 |
Why?
|
Spleen | 1 | 2017 | 2295 | 0.020 |
Why?
|
Cholesterol Ester Transfer Proteins | 1 | 2012 | 113 | 0.020 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2000 | 2205 | 0.020 |
Why?
|
Disease Progression | 2 | 2021 | 13640 | 0.020 |
Why?
|
Prospective Studies | 4 | 2022 | 54871 | 0.020 |
Why?
|
Kidney Tubules, Proximal | 1 | 2012 | 386 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2021 | 3511 | 0.020 |
Why?
|
Genes, Recessive | 1 | 2012 | 625 | 0.020 |
Why?
|
Biopsy | 1 | 2021 | 6779 | 0.020 |
Why?
|
Calorimetry, Indirect | 1 | 2009 | 176 | 0.020 |
Why?
|
Stroke Volume | 1 | 2022 | 5618 | 0.020 |
Why?
|
Down-Regulation | 1 | 2015 | 2931 | 0.020 |
Why?
|
Xenopus laevis | 1 | 2012 | 965 | 0.020 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2020 | 2326 | 0.020 |
Why?
|
Particle Size | 1 | 2012 | 1634 | 0.020 |
Why?
|
Family Health | 1 | 2012 | 1254 | 0.020 |
Why?
|
Oocytes | 1 | 2012 | 1168 | 0.020 |
Why?
|
Depressive Disorder | 1 | 2000 | 3715 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2019 | 3070 | 0.020 |
Why?
|
Disease Management | 1 | 2017 | 2533 | 0.020 |
Why?
|
Hyperlipidemias | 1 | 2011 | 771 | 0.020 |
Why?
|
Thinness | 1 | 2008 | 482 | 0.010 |
Why?
|
Sex Factors | 1 | 2019 | 10619 | 0.010 |
Why?
|
Anthropometry | 1 | 2009 | 1336 | 0.010 |
Why?
|
Pedigree | 1 | 2012 | 4539 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2020 | 4353 | 0.010 |
Why?
|
Research Design | 1 | 2020 | 6207 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 10384 | 0.010 |
Why?
|
Cholesterol, HDL | 2 | 2000 | 1812 | 0.010 |
Why?
|
Cholesterol, LDL | 1 | 2013 | 2392 | 0.010 |
Why?
|
Leptin | 1 | 2011 | 1596 | 0.010 |
Why?
|
Exercise Test | 1 | 2010 | 2188 | 0.010 |
Why?
|
Multivariate Analysis | 2 | 2009 | 12064 | 0.010 |
Why?
|
Cosyntropin | 1 | 2001 | 34 | 0.010 |
Why?
|
Infant | 1 | 2023 | 36461 | 0.010 |
Why?
|
Motor Activity | 1 | 2010 | 2711 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2012 | 13411 | 0.010 |
Why?
|
Dehydroepiandrosterone Sulfate | 1 | 2001 | 240 | 0.010 |
Why?
|
Skinfold Thickness | 1 | 2000 | 164 | 0.010 |
Why?
|
Scintillation Counting | 1 | 2000 | 36 | 0.010 |
Why?
|
Body Constitution | 1 | 2001 | 273 | 0.010 |
Why?
|
Viscera | 1 | 2001 | 138 | 0.010 |
Why?
|
Wasting Syndrome | 1 | 2000 | 96 | 0.010 |
Why?
|
Weight Lifting | 1 | 2000 | 130 | 0.010 |
Why?
|
Recovery of Function | 1 | 2010 | 2976 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2012 | 9547 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2012 | 17608 | 0.010 |
Why?
|
Chorionic Gonadotropin | 1 | 2001 | 458 | 0.010 |
Why?
|
Injections, Intramuscular | 1 | 2000 | 551 | 0.010 |
Why?
|
Risk | 1 | 2010 | 9602 | 0.010 |
Why?
|
Pulsatile Flow | 1 | 1998 | 318 | 0.010 |
Why?
|
Reverse Transcriptase Inhibitors | 1 | 2000 | 618 | 0.010 |
Why?
|
Arm | 1 | 2000 | 591 | 0.010 |
Why?
|
Ultrasonography | 1 | 2010 | 5992 | 0.010 |
Why?
|
Genetic Variation | 1 | 2012 | 6612 | 0.010 |
Why?
|
Physical Fitness | 1 | 2001 | 743 | 0.010 |
Why?
|
Lipoproteins | 1 | 2001 | 871 | 0.010 |
Why?
|
Electric Impedance | 1 | 2000 | 791 | 0.010 |
Why?
|
Leg | 1 | 2000 | 1087 | 0.010 |
Why?
|
Protease Inhibitors | 1 | 1999 | 750 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2020 | 59550 | 0.010 |
Why?
|
Abdomen | 1 | 2001 | 1137 | 0.010 |
Why?
|
Energy Intake | 1 | 2001 | 2142 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2012 | 12806 | 0.010 |
Why?
|
Cross-Over Studies | 1 | 1999 | 2108 | 0.010 |
Why?
|
Hypertension | 1 | 2011 | 8616 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2000 | 2693 | 0.010 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2000 | 6020 | 0.010 |
Why?
|
Massachusetts | 1 | 2000 | 8891 | 0.000 |
Why?
|
Skin | 1 | 2001 | 4499 | 0.000 |
Why?
|
Mice | 1 | 2012 | 81889 | 0.000 |
Why?
|
Phenotype | 1 | 2000 | 16724 | 0.000 |
Why?
|
Animals | 1 | 2012 | 168930 | 0.000 |
Why?
|
Quality of Life | 1 | 1999 | 13476 | 0.000 |
Why?
|
Time Factors | 1 | 1999 | 40149 | 0.000 |
Why?
|